These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 1677434)

  • 1. New potent verapamil derivatives that reverse multidrug resistance in human renal carcinoma cells and in transgenic mice expressing the human MDR1 gene.
    Mickisch GH; Merlino GT; Aiken PM; Gottesman MM; Pastan I
    J Urol; 1991 Aug; 146(2):447-53. PubMed ID: 1677434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency, and toxicity.
    Mickisch GH; Licht T; Merlino GT; Gottesman MM; Pastan I
    Cancer Res; 1991 Oct; 51(19):5417-24. PubMed ID: 1680550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms and modulation of multidrug resistance in primary human renal cell carcinoma.
    Mickisch GH; Roehrich K; Koessig J; Forster S; Tschada RK; Alken PM
    J Urol; 1990 Sep; 144(3):755-9. PubMed ID: 1974934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance.
    Mickisch GH; Merlino GT; Galski H; Gottesman MM; Pastan I
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):547-51. PubMed ID: 1671173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines.
    Park JG; Lee SK; Hong IG; Kim HS; Lim KH; Choe KJ; Kim WH; Kim YI; Tsuruo T; Gottesman MM
    J Natl Cancer Inst; 1994 May; 86(9):700-5. PubMed ID: 7908989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH.
    Zacherl J; Hamilton G; Thalhammer T; Riegler M; Cosentini EP; Ellinger A; Bischof G; Schweitzer M; Teleky B; Koperna T
    Cancer Chemother Pharmacol; 1994; 34(2):125-32. PubMed ID: 7910786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs.
    Chaudhary PM; Roninson IB
    J Natl Cancer Inst; 1993 Apr; 85(8):632-9. PubMed ID: 8096875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of the new vinca-alkaloid S 12363 alone or in combination with verapamil on a human multidrug resistant renal carcinoma xenograft.
    Berlion M; Arvelo F; Leonce S; Bourgeois Y; Rigaudy P; Bizzari JP; Poupon MF
    In Vivo; 1993; 7(5):399-405. PubMed ID: 7906553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer.
    Salmon SE; Dalton WS; Grogan TM; Plezia P; Lehnert M; Roe DJ; Miller TP
    Blood; 1991 Jul; 78(1):44-50. PubMed ID: 1676918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles.
    Horio M; Lovelace E; Pastan I; Gottesman MM
    Biochim Biophys Acta; 1991 Jan; 1061(1):106-10. PubMed ID: 1671642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verapamil enhances doxorubicin activity in cultured human renal carcinoma cells.
    Lai T; Collins CM; Hall P; Morgan AP; Smith PJ; Stonebridge BR; Symes MO
    Eur J Cancer; 1993; 29A(3):378-83. PubMed ID: 8104443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.
    Dietel M; Herzig I; Reymann A; Brandt I; Schaefer B; Bunge A; Heidebrecht HJ; Seidel A
    J Cancer Res Clin Oncol; 1994; 120(5):263-71. PubMed ID: 7907333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-glycoprotein binding and modulation of the multidrug-resistant phenotype by estramustine.
    Speicher LA; Barone LR; Chapman AE; Hudes GR; Laing N; Smith CD; Tew KD
    J Natl Cancer Inst; 1994 May; 86(9):688-94. PubMed ID: 7908988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical reversal of drug resistance.
    Goldstein LJ
    Curr Probl Cancer; 1995; 19(2):65-124. PubMed ID: 7600845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of small-cell lung cancer xenografts to chemotherapy: multidrug resistance and direct clinical correlates.
    Poupon MF; Arvelo F; Goguel AF; Bourgeois Y; Jacrot M; Hanania N; Arriagada R; Le Chevalier T
    J Natl Cancer Inst; 1993 Dec; 85(24):2023-9. PubMed ID: 7902445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma.
    Huang CC; Wu MC; Xu GW; Li DZ; Cheng H; Tu ZX; Jiang HQ; Gu JR
    J Natl Cancer Inst; 1992 Feb; 84(4):262-4. PubMed ID: 1346405
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of P-glycoprotein and multidrug resistance in renal cell carcinoma.
    Naito S; Sakamoto N; Kotoh S; Goto K; Matsumoto T; Kumazawa J
    Eur Urol; 1993; 24(1):156-60. PubMed ID: 8103456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Circumvention of the intrinsic multidrug-resistance in renal cell carcinoma].
    Kakehi Y; Segawa T; Hashimura T; Yoshida O
    Hinyokika Kiyo; 1992 Nov; 38(11):1319-24. PubMed ID: 1485588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody MRK16 reverses the multidrug resistance of multidrug-resistant transgenic mice.
    Mickisch GH; Pai LH; Gottesman MM; Pastan I
    Cancer Res; 1992 Aug; 52(16):4427-32. PubMed ID: 1353705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexverapamil to modulate vinblastine resistance in metastatic renal cell carcinoma.
    Mickisch GH; Noordzij MA; vd Gaast A; Gebreamlack P; Köhrmann KU; Mogler-Drautz E; Kupper H; Schröder FH
    J Cancer Res Clin Oncol; 1995; 121 Suppl 3():R11-6. PubMed ID: 8698736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.